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Abstract Oxidative stress is implicated in various
pathological conditions of the retina and optic nerve.
Peroxiredoxins (Prdxs) comprise a recently characterized
family of antioxidant enzymes. To date, little information
exists regarding the distribution of Prdxs in the eye. Herein,
we employed a combination of qRT-PCR, immunohisto-
chemistry and Western blotting to determine the level of
expression and distribution of the six Prdx isoforms in the
retina and optic nerve of the rat. In addition, we performed
some parallel analyses on the common marmoset (Cal-
lithrix Jacchus). In the rat, all of the Prdx transcripts were
expressed in relatively high amounts in both retina and
optic nerve, with abundances ranging from approximately
3–50 % of the level of the housekeeping gene cyclophilin.
With regard to protein expression, each isoform was
detected in the retina and optic nerve by either Western
blotting and/or immunohistochemistry. Excepting Prdx4,
there was a good correspondence between the rodent and
primate results. In the retina, Prdx1 and Prdx2 were prin-
cipally localized to neurons in the inner nuclear layer and
cone photoreceptors, Prdx3 and Prdx5 displayed charac-
teristic mitochondrial immunolabeling, while Prdx6 was
associated with astrocytes and Mu¨ller cells. In the optic
nerve, Prdx1 was robustly expressed by oligodendrocytes,
Prdx3 and Prdx5 were observed in axons, and Prdx6 was
restricted to astrocytes. The present findings augment our
understanding of the distribution and expression of the
Prdxs in the retina and optic nerve of rodents and primates
and lay the foundation for subsequent analysis of their
involvement in relevant blinding diseases.
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Introduction
Oxidative stress signifies a loss of balance between the
cellular processes that produce reactive oxygen (and reac-
tive nitrogen) species and the endogenous antioxidant
defenses responsible for their elimination. Cumulative
oxidative stress results in damage to DNA, proteins and
lipids, and is linked to the etiology of numerous CNS
disorders. The retina is particularly vulnerable to oxidative
stress owing to its relatively sparse vasculature, its constant
exposure to light, and most importantly its exceptional
oxygen and energy demands (Ames et al. 1992). The
demands of the retina are principally caused by the high
metabolic rate of photoreceptors, which facilitate the pro-
cesses of phototransduction and neurotransmission, but
also reflect the mitochondrial-rich nature of retinal gan-
glion cells (RGCs), whose extensive axons remain
unmyelinated prior to passing through the lamina cribrosa.
Oxidative stress is hypothesized to play a key pathogenic
role in development of a number of sight-threatening
conditions, most notably age-related macular degeneration,
diabetic retinopathy and glaucoma (Kiang et al. 2014). The
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ability of a tissue to withstand oxidative stress is related to
the effectiveness of the endogenous antioxidant defense
system, which comprises both enzymatic and non-enzy-
matic components.
Peroxiredoxins (Prdxs) are a family of highly conserved,
low molecular weight (20–30 kD) thiol peroxidases that
scavenge hydrogen peroxide, alkyl hydroperoxides, and
peroxynitrite in living cells. Six Prdx isoforms (Prdx1-6)
are expressed in mammalian tissues, which differ in
structure, catalytic mechanisms and subcellular compart-
mentalization (Hanschmann et al. 2013). Prdxs1, -2 and -6
are typically located within the cytosol, Prdx3 is exclu-
sively, and Prdx5 predominantly, localized to mitochon-
dria, while Prdx4 is mainly reported to be associated with
the endoplasmic reticulum. Interestingly, the Prdx family
was not discovered until decades later than the other major
cellular peroxide reducing enzymes, catalase and glu-
tathione peroxidases (Chae et al. 1994), but owing to a
combination of their high reactivity and remarkable
abundance, it has been predicted that greater than 90 % of
mitochondrial peroxides and 99 % of cytosolic peroxides
are reduced by Prdxs (Karplus 2014). As a consequence of
their status as the major cellular peroxide-removal mech-
anism, it is becoming apparent that Prdxs have a pivotal
role to play in the response of cells to oxidative stress.
Moreover, increasing evidence suggests that certain Prdxs
also act as redox sensors: under conditions of oxidative
stress, hyperoxidation of the Prdx molecule can occur via
binding of a second peroxide substrate, resulting in the
cellular buildup of Prdx oxidation products and the local
accumulation of hydrogen peroxide (Rhee and Woo 2011).
The physiological purpose of this reaction is not com-
pletely understood, as it necessarily entails depletion of the
levels of functional Prdxs, but suggested rationalizations
include the conservation of redox power during periods of
oxidative stress, the initiation of downstream redox sig-
naling pathways, and the ability of hyperoxidised Prdxs to
act as protein chaperones (Karplus 2014). Hyperoxidised
Prdxs have been proposed as ideal candidates to serve as
endogenous biomarkers of oxidative stress (Poynton and
Hampton 2014).
In order to elucidate the roles of the various Prdx iso-
forms in the protection of retinal neurons from oxidative
stress occurring in diseases such as age-related macular
degeneration, diabetic retinopathy and glaucoma, and fur-
ther to investigate whether this class of antioxidant
enzymes represents a suitable target for neuroprotection
strategies, it is first necessary to characterize the basal
distribution of the Prdx isoforms. To date, very little
information is available concerning the expression of the
Prdxs in the various neuronal and glial cell types of the
retina and optic nerve. Prdx1 and -2 have both been
identified in human retinal sections, but double labeling
immunofluorescence using cell type specific markers was
not performed (Klebe et al. 2014), while Prdx3 has been
shown to be highly expressed in primate retina (Moreira
et al. 2008). In the brain, the distribution of the Prdxs has
been examined in detail (Mizusawa et al. 2000; Jin et al.
2005; Kim et al. 2008; Aon-Bertolino et al. 2011; Dam-
meyer and Arner 2011; Godoy et al. 2011; Goemaere and
Knoops 2012). The combined data reveal that each of the
isoforms displays a widespread pattern of expression, but
that a marked variation exists amongst the six isoforms,
both in terms of expression by specific cell types and
between different brain regions.
The aim of the present study was to determine the
expression and distribution of the six members of the Prdx
family in the retina and optic nerve of the rat. In addition,
we performed some parallel analyses on retina and optic
nerve from the common marmoset (Callithrix Jacchus). To
achieve the goals of the study, we employed a combination
of qRT-PCR, Western blotting and immunohistochemistry,
using optimized primer sets and well-characterized anti-
bodies specific to the individual Prdx isoforms.
Materials and methods
Animals and tissue processing
This study was approved by the SA Pathology/CHN Ani-
mal Ethics Committee (Adelaide, Australia) and conforms
with the Australian Code of Practice for the Care and Use
of Animals for Scientific Purposes, 2013. Adult Sprague–
Dawley rats (approximately 250 g) were housed in a
temperature- and humidity-controlled room with a 12-h
light, 12-h dark cycle and were provided with food and
water ad libitum. A total of 14 rats were used in the study.
The left retinas and optic nerves of 8 rats were dissected
and used for qRT-PCR. The corresponding right eyes and
optic nerves were placed in Davidson’s fixative and sub-
sequently used for immunohistochemistry. The left retinas
and optic nerves of a further 6 rats were dissected and used
for Western blotting. The corresponding right eyes and
optic nerves were fixed in formalin. Thus, for qRT-PCR
and Western blotting, each ‘‘n’’ represents an independent
replicate. All rats were killed by transcardial perfusion with
physiological saline under deep anesthesia (100 mg/kg
ketamine and 10 mg/kg xylazine). Both eyes with optic
nerves attached were enucleated immediately. The brain
was also taken when necessary.
Human ocular tissue for analysis was obtained from the
Eye-Bank of South Australia, Flinders Medical Centre
(Adelaide, Australia) following the guidelines of the
Southern Adelaide Clinical Human Research Ethics Com-
mittee; all had been screened to make sure there was no
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underlying ocular disease and all were from Caucasian
donors between the ages of 50 and 65. Archived human
brain tissue for analysis was obtained from the SA Brain
Bank (Adelaide, Australia). Following ethical approval
from the SA Pathology/CHN Animal Ethics Committee
(Adelaide, Australia), we were able to obtain ocular tissue
from three adult marmosets (Callithrix jacchus) belonging
to the colony housed at the Queen Elizabeth Hospital
(South Australia, Australia) that were being euthanized.
We are grateful to Dr Toby Coates for participating in this
tissue sharing initiative, which has obvious benefits from
an ethical perspective.
Globes and optic nerves that were subsequently used for
immunohistochemistry were immersion-fixed in David-
son’s solution for 24 h, then transferred to 70 % ethanol
until processing. Davidson’s solution, which comprises 2
parts formaldehyde (37 %), 3 parts 100 % ethanol, 1 part
glacial acetic acid and 3 parts water, is the preferred fixa-
tive for whole eyes as it provides optimal tissue morphol-
ogy while avoiding retinal detachment. Alternatively,
globes were immersion-fixed in 10 % buffered formalin for
at least 24 h until processing. All tissues were then pro-
cessed for routine paraffin-embedded sections. Globes
were embedded sagittally, optic nerves longitudinally. In
all cases, 4 lm sections were cut.
Immunohistochemistry
Tissue sections were deparaffinised, rinsed in 100 %
ethanol and treated for 20 min with 0.5 % H2O2 in absolute
methanol to block endogenous peroxidase activity before
being taken to phosphate-buffered saline (PBS). Antigen
retrieval was then achieved by microwaving the sections in
either 1 mM EDTA buffer, pH 8.0 (Davidson’s fixed tis-
sue) or 10 mM citrate buffer, pH 6.0 (formalin-fixed tissue)
for 10 min at 95–100 C. Subsequently, tissue sections
were blocked in PBS containing 3 % normal horse serum,
incubated overnight at room temperature in primary anti-
body (containing 3 % normal horse serum; see Table 1),
followed by consecutive incubations with biotinylated
secondary antibody (1:250; Vector, Burlingame, CA) and
streptavidin-peroxidase conjugate (1:1000; Pierce, Rock-
ford, IL). Color development was achieved using NovaRed
substrate kit (Vector). Sections were counterstained with
haematoxylin, dehydrated, cleared in histolene and moun-
ted in DPX.
For double labeling fluorescent immunohistochemistry,
visualization of one antigen was achieved using a 3-step
procedure (primary antibody, biotinylated secondary anti-
body, streptavidin-conjugated AlexaFluor 594), while the
second antigen was labeled by a 2-step procedure (primary
antibody, secondary antibody conjugated to AlexaFluor
488). Sections were prepared as above, then incubated
overnight at room temperature in the appropriate combi-
nation of primary antibodies. On the following day, sec-
tions were incubated with the appropriate biotinylated
secondary antibody (1:250) for the 3-step procedure plus
the correct secondary antibody conjugated to AlexaFluor
488 (1:250; Invitrogen, Carlsbad, CA) for the 2-step pro-
cedure for 30 min, followed by streptavidin-conjugated
AlexaFluor 594 (1:500; Invitrogen) for 1 h. Sections were
then mounted using anti-fade mounting medium (Dako
fluorescent mounting medium; Dako, Carpinterı´a, CA) and
examined under a confocal fluorescence microscope.
Western blotting
Tissues were processed for Western blotting as previously
described (Chidlow et al. 2010). In brief, entire retinas, optic
nerves and brain samples were dissected and sonicated in
homogenization buffer (20 mM Tris–HCl, pH 7.4, 25 C;
containing 2 mM EDTA, 0.5 mM EGTA, 1 mM dithio-
threitol, 50 lg/ml leupeptin, 50 lg/ml pepstatin A, 50 lg/ml
aprotinin and 0.1 mM phenylmethylsulphonyl fluoride).
Note: brain tissue used as positive control tissue was taken
from the cerebral cortex. An equal volume of sample buffer
(62.5 mM Tris–HCl, pH 7.4, containing 4 % SDS, 10 %
glycerol, 10 % b-mercaptoethanol and 0.002 % bromophe-
nol blue) was then added and samples were boiled; protein
concentrations in each sample were equalized with the
bicinchoninic acid assay (Sigma-Aldrich, Sydney, NSW,
Australia). Electrophoresis was performed on 12 % dena-
turing polyacrylamide gels after which proteins were trans-
ferred to polyvinylidene fluoride membranes (Bio-Rad,
Gladesville, Australia) for immunoprobing. Membranes
were incubated with the appropriate antisera (as detailed in
Table 1), overnight, and labeling carried out using a multi-
step detection procedure: first, appropriate biotinylated
secondary antibodies were reacted with membranes and then
streptavidin-peroxidase conjugates were applied. Blots were
developed with a 0.016 % solution of 3-amino-9-ethylcar-
bazole in 50 mM sodium acetate (pH 5) containing 0.05 %
Tween-20 and 0.03 % H2O2. Images were acquired from
labeled blots and analyzed for densitometry using the soft-
ware program, Adobe PhotoShop CS2 (Adobe Australia,
Sydney, New South Wales, Australia). Densitometry values
were then normalized for b-actin. Statistical comparison
between the level of each isoform in retina versus optic nerve
was carried out by Student’s unpaired t test.
Real-time RT-PCR
Reverse transcription polymerase chain reaction (RT-PCR)
studies were carried out as described previously (Chidlow
et al. 2008, 2010). In brief, entire retinas and optic nerves
were dissected, total RNA was isolated and first strand
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cDNA was synthesized from DNase-treated RNA. Real-
time PCR reactions were carried out in 96-well optical
reaction plates using the cDNA equivalent of 20 ng total
RNA for each sample in a total volume of 20 ll containing
19 SYBR Green PCR master mix (Bio-Rad) forward and
reverse primers. The thermal cycling conditions were
95 C for 3 min and 40 cycles of amplification comprising
95 C for 12 s, annealing temperature (Table 2) for 30 s
and 72 C for 30 s. After the final cycle of the PCR, primer
specificity was checked by the dissociation (melting) curve
method. In addition, specific amplification was confirmed
by electrophoresis of PCR products on 3 % agarose gels.
PCR assays were performed using the IQ5 icycler (Bio-
Rad) and all samples were run in duplicate. Threshold
cycles were calculated using IQ5 icycler Software (Bio-
Rad). All values were normalized using the endogenous
reference gene, cyclophilin, and results expressed as
mean ± SEM.
Primer pairs (Table 2) were designed from sequences
contained in the Genbank database using the primer design
software Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0/pri
mer3/) and were selected to amplify sequences that span-
ned at least one intron. Primer sequences were analyzed for
Tm (melting temperature), secondary structure and primer-
dimer formation with NetPrimer analysis software (http://
www.premierbiosoft.com/netprimer) and verified both for
their specificity to the target Prdx sequence and for their
lack of specificity to the other Prdxs. The results showed
that all six Prdx mRNAs amplified with high efficiency and
linearity during real-time PCR. Mean amplification effi-
ciencies, as determined by plotting cycle threshold as a
function of initial cDNA quantity, ranged from 1.9 to 2.0.
Alternative primers sets were designed and tested for each
of the six Prdx mRNA species to ensure that cycle
threshold values obtained were an accurate reflection of
tissue abundance.
Table 1 Primary antibodies
Antigen Immunogen Source Dilution
PRDX1 Recombinant human peroxiredoxin 1 Hormonology Laboratory of Marloie (Belgium),
rabbit polyclonal, No. UC232
1:15,000IHC
1:8000W
PRDX2 Recombinant human peroxiredoxin 2 Hormonology Laboratory of Marloie (Belgium),
rabbit polyclonal, No. UC198
1:1000IHC
1:4000W
PRDX3 Recombinant human peroxiredoxin 3 (without
mitochondrial targeting sequence)




PRDX4 Recombinant human peroxiredoxin 4 (without
secretion signal peptide)
Hormonology Laboratory of Marloie (Belgium),
rabbit polyclonal, No. UC194
1:4000IHC
1:3000W
PRDX5 Recombinant human peroxiredoxin 5 (without
mitochondrial targeting sequence)
Hormonology Laboratory of Marloie (Belgium),
rabbit polyclonal, No. G234
1:10,000IHC
1:5000 W
PRDX6 Rat recombinant non-Selenium glutathione
peroxidase
Antibody Technology Australia Pty Ltd, rabbit
polyclonal, catalog No. P6R
1:5000IHC
1:2500W
b-actin Slightly modified b cytoplasmic actin N-terminal
peptide
Sigma, mouse monoclonal, clone AC-15 1:20,000W
Calretinin Recombinant rat calretinin Millipore, mouse monoclonal, clone 6B8.2 1:200f
Chx10 Recombinant human Chx10 protein, N-terminal Millipore, sheep polyclonal, catalog No. AB 9016 1:1500f
CRALBP Recombinant full length human CRALBP Abcam, mouse monoclonal, clone B2 1:400f
Cytochrome
oxidase subunit I
OxPhos IV complexes isolated from bovine heart,
bovine liver, and human heart
Invitrogen, mouse monoclonal, clone 1D6 1:1000IHC
FGF-2 Purified bovine brain basic FGF Millipore, mouse monoclonal, clone bFM-2 1:500IHC
Glutamine
synthetase
Sheep glutamine synthetase aa. 1–373 BD Transduction, mouse monoclonal, catalog No.
610517
1:500f
Olig2 Recombinant mouse Olig-2 Millipore, rabbit polyclonal, catalog No. 9610 1:8000IHC
Parvalbumin Purified frog muscle parvalbumin Sigma, mouse monoclonal, clone PARV-19 1:400f
PKCa Purified bovine brain protein kinase C Abcam, mouse monoclonal, clone MC5 1:200f
SOD2 human/rat/mouse SOD2 aa. 25–43 Antibody Technology Australia Pty Ltd, rabbit
polyclonal, catalog No. SOD2R
1:1000IHC
Vimentin Purified vimentin from porcine eye lens Dako, mouse monoclonal, clone V9 1:200f
IHC dilution used for 3-step colorimetric or 3-step fluorescent immunohistochemistry, f dilution used for 2-step fluorescent immunohisto-
chemistry, W dilution used for Western blotting
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Antibody characterization
Full details of all the antisera and antibodies used are
shown in Table 1.
The polyclonal rabbit Prdx1 antiserum raised against
recombinant human Prdx1 was obtained as previously
described (Goemaere and Knoops 2012). It recognizes a
band at 22 kDa by Western blotting performed on mouse
(Goemaere and Knoops 2012), human (Fig. 1) and rat
(Fig. 1) brain extracts. By immunohistochemistry, the
Prdx1 antibody has been shown to produce high signal-to-
background labeling in mouse brain, with robust expres-
sion observed in oligodendrocytes (Goemaere and Knoops
2012). Preadsorption with the immunizing protein elimi-
nated Prdx1-specific staining, while incubation with
preimmune serum alone gave no positive labeling (Goe-
maere and Knoops 2012).
The polyclonal rabbit Prdx2 antiserum raised against
recombinant human Prdx2 was obtained as previously
described (Goemaere and Knoops 2012). It recognizes a
protein of 22 kDa by Western blotting performed on mouse
(Goemaere and Knoops 2012), human (Fig. 3) and rat
(Fig. 3) brain extracts. By immunohistochemistry, the
Prdx2 antibody has been shown to give rise to high signal-
to-background labeling in mouse brain, with an exclusively
neuronal pattern of staining (Goemaere and Knoops 2012).
Preadsorption with the immunizing protein eliminated
Prdx2-specific staining, while incubation with preimmune
serum alone elicited no labeling (Goemaere and Knoops
2012).
Rabbit anti-Prdx3 was acquired from Abfrontier (LF-
PA0030). This antiserum detects a major protein band of
approximately 22 kDa on western blot of mouse
(Goemaere and Knoops 2012), human (Fig. 5) and rat
(Fig. 5) brain extracts. A doublet band is detectable in
some tissues that may correspond to a modified form of the
protein (Goemaere and Knoops 2012). By immunohisto-
chemistry, the Prdx3 antibody has been shown to be widely
expressed in mouse brain neurons (Goemaere and Knoops
2012), a pattern which matched of the corresponding
expression of Prdx3 mRNA (Allen Brain Atlas, Image
series 70743842). Preadsorption with the immunizing
protein eliminated Prdx3-specific staining.
The polyclonal rabbit Prdx4 antiserum raised against
recombinant human Prdx4 was obtained as previously
described (Goemaere and Knoops 2012). By Western
blotting, Prdx4 antiserum recognized a 29 kDa protein in
mouse brain extract with two minor additional protein
bands at around 55 kDa (Goemaere and Knoops 2012).
The Prdx4 staining was significantly diminished when
antiserum was preadsorbed with the antigen, while incu-
bation with preimmune serum showed a slight neuronal
labeling (Goemaere and Knoops 2012). In the present
study, Prdx4 antiserum revealed a single, intense band at
approximately 26 kDa in human brain extracts (Fig. 8),
and a less pronounced band at 26 kDa in rat brain extract
with additional, higher molecular weight bands (Fig. 8).
Note that mouse anti-Prdx4 from Abfontier (LF-MA0014),
and four mouse anti-Prdx4 antibodies from Developmental
Studies Hybridoma Bank (CPTC-PRDX4-1, CPTC-
PRDX4-2, CPTC-PRDX4-3, CPTC-PRDX4-4) were tested
in this study but none yielded a band at the expected
molecular weight in extracts from rat retina or brain or
human brain (data not shown).
The polyclonal rabbit Prdx5 antiserum raised against
recombinant human Prdx5 was obtained as previously
Table 2 Primer sequences for mRNAs amplified by real-time RT-PCR
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described (Wang et al. 2001). It recognizes a protein band
at the expected molecular weight, 17 kDa, in human
peripheral nervous tissue (Lu et al. 2006), mouse (Goe-
maere and Knoops 2012), human (Fig. 6) and rat (Fig. 6)
brain extracts. By immunohistochemistry, the Prdx5 anti-
body elicited high signal-to-background labeling in mouse
brain, with a prominent subcellular targeting to mito-
chondria (Goemaere and Knoops 2012). Preadsorption with
the immunizing protein eliminated Prdx5-specific staining,
while incubation with preimmune serum alone yielded no
labeling (Goemaere and Knoops 2012).
Rabbit anti-Prdx6 was obtained from Antibody Tech-
nology (P6R). This antiserum detects a major protein band
of approximately 26 kDa on western blot of human (Power
et al. 2002) (Fig. 10) and rat (Fig. 10) brain extracts. By
immunohistochemistry, the Prdx6 antibody elicited high
signal-to-background labeling in human brain, with an
exclusively astrocytic localization, while incubation with
preimmune serum alone yielded no labeling (Power et al.
2002). This pattern of immunolabeling is identical to that
produced in mouse brain using a different Prdx6 antibody
(Goemaere and Knoops 2012).
For all Prdx Western blots, additional weak higher
molecular weight bands seen in some tissues are related to
the secondary antibody alone and typically occur when
color development occurs more slowly.
Mouse anti-b-actin antibody was used in this study as a
loading control in western blotting. As expected, it pro-
vided a single protein band located at 42 kDa.
Mouse anti-cytochrome oxidase subunit I (clone 1D6)
was raised against OxPhos IV complexes isolated from
bovine heart, bovine liver and human heart, and recognizes
a single 16-kDa protein band on immunoblots (He et al.
2003). The distribution of labeling in our hands was
identical to previous descriptions in retinal tissue (Mervin
and Stone 2002; Raven et al. 2008).
Rabbit anti-Superoxide dismutase (SOD2) was raised
against a peptide corresponding to aa. 25-43 of human/
rat/mouse SOD2 (Antibody Technology, SOD2R). It rec-
ognizes a protein band at the expected molecular weight,
approximately 23 kDa, by Western blotting in rat retinal
and brain samples (data not shown), and demarcates a
characteristic mitochondrial pattern of labeling in tissue
sections.
Mouse anti-calretinin (clone 6B8.2) was used to label
amacrine cells and RGCs, as has previously been shown in
rat retina (Nivison-Smith et al. 2013). Specificity within the
present study was confirmed by the characteristic pattern of
labeling observed.
Parvalbumin is a marker of AII amacrine cells in the rat
retina (Wassle et al. 1993). The specificity of clone PARV-
19 for use in rat retina has been repeatedly demonstrated
(Chidlow et al. 2011; Nivison-Smith et al. 2013).
The polyclonal antiserum against Chx10 protein (Mil-
lipore, ab9016) is routinely used to identify bipolar cell
bodies in the retina (Chow et al. 2004; Dorval et al. 2006).
The antibody reacts with a 46–50 kDa protein in rat and
mouse retinal tissue (Wood et al. 2010).
Mouse anti-PKCa (clone MC5) is a widely used marker
of rod bipolar cells in various species including rat (Gre-
ferath et al. 1990; Wassle et al. 1991) and marmoset
(Haverkamp et al. 2003). Western blotting of rat retinal
extracts reveals a single protein band of the expected
molecular weight, 80 kDa (Chidlow et al. 2011).
The monoclonal antibody to FGF-2 (clone bFM-2) is
highly specific for FGF-2 from bovine, human, rat, and
mouse sources and does not cross-react with FGF-1. It
principally recognizes a protein band at 22 kDa in rat
spinal cord tissue (Tripathi and McTigue 2008). FGF-2 can
be used to identify Mu¨ller cells in rat retina; it is present in
a characteristic nuclear pattern of staining (Xiao et al.
1998; Chidlow et al. 2013).
Mouse anti-glutamine synthetase (clone GS-6) was used
to label Mu¨ller cells, as has been previously shown in
rodent retinas (Vessey et al., 2011, 2014). It recognizes a
single protein band of 45 kDa on immunoblots from rat
brain (see manufacturer’s data sheet) and in mouse retina
(Chen and Weber 2002). The same antibody was also used
to label optic nerve oligodendrocytes (Domercq et al. 1999;
Chidlow et al. 2014).
CRALBP is a widely used Mu¨ller cell marker in the retina.
Mouse anti-CRALBP (clone B2) recognizes a single protein
band of the expected molecular weight, 36 kDa, by Western
blotting of rat retina (see manufacturer’s data sheet).
The monoclonal antibody to vimentin (clone V9) has
been used extensively for identifying glial cells in rat tis-
sues. It recognizes a single protein band of the expected
molecular weight, 57 kDa, when used for Western blotting
(Wood et al. 2012).
The Olig-2 rabbit polyclonal antibody (Millipore, ab9610)
was used in this study in order to label cells of the oligoden-
drocyte lineage. Olig2 transcription factor has been repeatedly
shown to be expressed within oligodendrocyte nuclei (Zhou
et al. 2000; Kim et al. 2011; Goemaere and Knoops 2012).
Specificity within the present study was confirmed by the
presence of positive nuclear labeling in a characteristic pattern
in tissue sections of optic nerve and brain.
Results
Expression of Prdx 1-6 mRNAs in retina and optic
nerve
Table 3 shows the expression levels of the mRNAs
encoding Prdxs 1–6, relative to the housekeeping gene
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cyclophilin, in rat retina. The first point to note is that all of
the Prdx transcripts are expressed in relatively high
amounts in the retina with cycle thresholds varying from
approximately 19–24 cycles, corresponding to 3–52 % of
the abundance of cyclophilin. Secondly, comparison of the
six isoforms reveals conspicuous differences in the levels
of expression, with Prdx1, -2 and -5 mRNAs present in
greater amounts than those encoding Prdx3, -4 and -6.
Table 4 shows the expression levels of the mRNAs
encoding Prdxs 1–6, relative to the housekeeping gene
cyclophilin, in rat optic nerve. Overall, the Prdx transcripts
are expressed at a similarly high level in the optic nerve to
the retina, with cycle thresholds varying from approxi-
mately 21–25 cycles, corresponding to 3–48 % of the
abundance of cyclophilin. Comparison of the six isoforms
reveals Prdx1 to be expressed at the highest level in the
optic nerve and Prdx3 to be least abundant. Necessarily, all
of these inferences are based on the assumption that each of
the primer pairs amplified with near identical efficiency.
This appears to be a valid supposition, as evidenced both
by preliminary analysis of plotting cycle threshold as a
function of initial cDNA quantity and from analysis of
alternate PCR assays using different primer sets.
Prdx1
Prdx1 is highly conserved among mammals with rodent,
marmoset and human sequences displaying virtually iden-
tical homology at the protein level. The antiserum used in
the current study was raised against recombinant human
Prdx1 and has previously been demonstrated to recognize
Table 3 Levels of peroxiredoxin mRNAs in retina expressed relative
to cyclophilin
Cyclophilin (CT) Prdx (CT) DCaT mRNA level
b
Prdx1 18.3 ± 0.1 20.6 ± 0.2 2.3 ± 0.1 0.22 ± 0.01
Prdx2 18.3 ± 0.1 19.3 ± 0.1 1.0 ± 0.1 0.52 ± 0.02
Prdx3 18.3 ± 0.1 22.4 ± 0.2 4.1 ± 0.1 0.07 ± 0.004
Prdx4 18.3 ± 0.1 23.6 ± 0.2 5.3 ± 0.1 0.03 ± 0.001
Prdx5 18.3 ± 0.1 20.8 ± 0.2 2.4 ± 0.1 0.20 ± 0.01
Prdx6 18.3 ± 0.1 23.1 ± 0.2 4.8 ± 0.1 0.04 ± 0.002
CT cycle threshold
a DCT Prdx CT - cyclophilin CT
b Prdx mRNA level expressed relative to cyclophilin, where n = 8
Fig. 1 Western blot analysis of
Prdx1 expression in brain, retina
and optic nerve. Molecular
weight markers (M, kDa) were
used to determine size of
detected gel products. a In
tissue extracts from human and
rat brain, a major band of the
expected molecular weight
(22 kDa) is apparent. b In tissue
extracts from marmoset retina
and optic nerve, a major band of
the expected molecular weight
is also apparent.
c Representative immunoblots
from rat retina and optic nerve
tissue extracts, together with
quantification of the levels of
Prdx1 protein. All values
(represented as mean ± SEM,
n = 6) are normalized for actin
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the murine equivalent by Western blotting and immuno-
histochemistry (Goemaere and Knoops 2012).
Western blotting
In samples prepared from human and rat brain—these tis-
sues were used as positive controls—the Prdx1 antiserum
recognized a major protein band of the expected molecular
weight, 22 kDa (Fig. 1a). In tissue extracts from marmoset
retina and optic nerve (Fig. 1b), as well as from rat retina
and optic nerve (Fig. 1c), a band of the same molecular
weight was also clearly evident. Analysis of retina and
optic nerve samples from six rats revealed a quantifiable
level of Prdx1 in all samples. Densitometry indicated that
there was a non-significant tendency for there to be a rel-
atively higher level of the Prdx1 protein in the retina versus
the optic nerve when normalized for actin (P = 0.11 by
Student’s unpaired t test; Fig. 1c).
Immunohistochemistry
Prdx1 immunoreactivity in both rat (Fig. 2a–c) and mar-
moset (Fig. 2j, k) retina localized to a population of cells in
the INL and to cone, but not rod, photoreceptors. Prdx1-
positive somas in the INL did not express the Mu¨ller cell
marker glutamine synthetase (Fig. 2m–o), indicating their
status as neurons; however, Prdx1 immunolabeling was
associated with some glutamine synthetase-positive pro-
cesses in close proximity to retinal ganglion cells
(Fig. 2m–o), suggesting that Mu¨ller cells may have limited
expression of Prdx1. In rat and marmoset optic nerve,
Prdx1 was robustly expressed by oligodendrocytes. In
addition, weaker staining was evident within axon bundles
(Fig. 2d, e, g–i, l). It is likely that oligodendrocytes are the
cell type that expresses the highest amount of Prdx1 in the
eye, as tenfold dilution of the anti-Prdx1 antiserum resulted
in the loss of all ocular Prdx1 immunolabeling with the
exception of that associated with oligodendrocytes (data
not shown).
Prdx2
Prdx2 is also highly conserved among mammals with
rodent, marmoset and human sequences displaying virtu-
ally identical homology at the protein level. The antiserum
used in the current study was raised against recombinant
human Prdx2 and has previously been demonstrated to
recognize the murine equivalent by Western blotting and
immunohistochemistry (Goemaere and Knoops 2012).
Western blotting
In samples prepared from human and rat brain—positive
control tissues—the Prdx2 antiserum recognized a major
protein band of the expected molecular weight, 22 kDa
(Fig. 3a). In tissue extracts from marmoset retina and optic
nerve (Fig. 3b), as well as from rat retina and optic nerve
(Fig. 3c), a band at the same molecular weight was also
apparent. Analysis of retina and optic nerve samples from
six rats revealed a quantifiable level of Prdx2 in each
sample. Densitometry revealed there to be a substantially
greater amount of Prdx2 in the retina versus the optic nerve
when normalized for actin (P\ 0.001 by Student’s
unpaired t test; Fig. 3c).
Immunohistochemistry
Prdx2 immunoreactivity in both rat (Fig. 4a, b) and mar-
moset (Fig. 4m, n) retina localized to a population of cells
in the INL. In addition, cone, but not rod, photoreceptors
were strongly labeled in the marmoset (Fig. 4n) and
Table 4 Levels of peroxiredoxin mRNAs in optic nerve expressed
relative to cyclophilin
Cyclophilin (CT) Prdx (CT) DCaT mRNA level
b
Prdx1 19.5 ± 0.1 20.6 ± 0.1 1.1 ± 0.1 0.48 ± 0.02
Prdx2 19.5 ± 0.1 21.3 ± 0.1 1.9 ± 0.1 0.30 ± 0.02
Prdx3 19.5 ± 0.1 24.6 ± 0.2 5.1 ± 0.1 0.03 ± 0.003
Prdx4 19.5 ± 0.1 23.7 ± 0.1 4.3 ± 0.1 0.06 ± 0.004
Prdx5 19.5 ± 0.1 22.2 ± 0.1 2.7 ± 0.1 0.17 ± 0.02
Prdx6 19.5 ± 0.1 23.3 ± 0.2 3.8 ± 0.1 0.08 ± 0.005
CT cycle threshold
a DCT Prdx CT - cyclophilin CT
b Prdx mRNA level expressed relative to cyclophilin, where n = 8
cFig. 2 Representative images of Prdx1 immunolabeling in rat (a–
i) and marmoset (j–o) retina and optic nerve. In the rat retina (a),
positive labeling for Prdx1 is associated with processes in close
proximity to retinal ganglion cells, a large population of cells in the
INL—predominantly the outer INL—and with a small number of
cells located within the ONL. Higher magnification images of the
ONL (b, c) indicate that these intensely labeled cells (arrow) are cone
photoreceptors owing to the presence of clumps of heterochromatin.
In the optic nerve, cells with the morphology and spatial arrangement
of oligodendrocytes (d, olig-2) are robustly labeled by the Prdx1
antiserum (e, f). In addition, weaker staining is evident within axon
bundles (e, f). Double labeling immunofluorescence shows a complete
co-localization of Prdx1 with glutamine synthetase in oligodendro-
cytes (g–i). In the marmoset, a similar pattern of distribution is
observed as the rat, with prominent labeling associated with cells in
the INL (j, k), with cone photoreceptors (j, k) and with optic nerve
oligodendrocytes (l). Double labeling of Prdx1 with the Mu¨ller cell
marker glutamine synthetase reveals that none of the Prdx1-positive
cells within the INL are Mu¨ller cells (m–o). Scale bar a, d, e, g–i,
j = 50 lm; b, k, L, m–o = 25 lm; c = 10 lm. GCL ganglion cell
layer, INL inner nuclear layer, ONL outer nuclear layer
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weakly labeled in the rat (Fig. 4b). Double labeling
experiments in the rat revealed that many Prdx2-positive
cells colocalized with the pan bipolar cell marker Chx10
(Fig. 4d–f). A much smaller number of Prdx2-positive cells
in the inner INL colocalized with the amacrine cell marker
calretinin. In contrast, Mu¨ller cell markers, such as FGF-2
(Fig. 4j–l) and CRALBP (data not shown), labeled a dis-
crete population of cells, indicating the absence of Prdx2
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from this cell type. Surprisingly, given the high level of
expression of Prdx2 mRNA and protein in rat optic nerve
tissue extracts, no unambiguously positive immunostaining
for Prdx2 was apparent, either in rat or marmoset optic
nerve sections (Fig. 4c, o).
Prdx3 and Prdx 5
Prdx3 and Prdx5, the mitochondrial Prdxs, are both highly
conserved among mammals. The antisera used in the cur-
rent study were raised against recombinant human Prdx3
and Prdx5 (both without mitochondrial targeting
sequence), respectively, and have been verified as recog-
nizing the murine equivalents by Western blotting and
immunohistochemistry (Goemaere and Knoops 2012).
Western blotting
Prdx3
In samples prepared from human and rat brain—positive
control tissues—the Prdx3 antiserum recognized a major
protein band of the expected molecular weight, 22 kDa
(Fig. 5a). In tissue extracts from marmoset (Fig. 5b) and
rat (Fig. 5c) retinas, positive reactivity was also apparent;
however, in optic nerve samples from marmoset and rat,
bands were undetectable under the assay conditions used.
Fig. 3 Western blot analysis of
Prdx2 expression in brain, retina
and optic nerve. Molecular
weight markers (M, kDa) were
used to determine size of
detected gel products. a In
tissue extracts from human and
rat brain, a major band of the
expected molecular weight
(22 kDa) is apparent. b In tissue
extracts from marmoset retina
and optic nerve, a major band of
the expected molecular weight
is also apparent.
c Representative immunoblots
from rat retina and optic nerve
tissue extracts, together with
quantification of the levels of
Prdx2 protein. All values
(represented as mean ± SEM,
n = 6) are normalized for actin,
where ***P\ 0.001 by
Student’s unpaired t test
cFig. 4 Representative images of Prdx2 immunolabeling in rat (a–
l) and marmoset (m–o) retina and optic nerve. In the rat retina (a, b),
positive labeling for Prdx2 is principally associated with a large
population of cells in the INL, predominantly the outer INL. In
addition, cone photoreceptors are weakly labeled (arrows). In the
optic nerve, no unambiguously positive staining was associated with
glial cells or axons (c). Double labeling immunofluorescence of the
retina reveals that Prdx2 typically colocalizes with the pan bipolar
cell marker Chx10 (d–f). Prdx2 is also associated with some amacrine
cells, as evidenced by co-localization with calretinin (g–i). In
contrast, Prdx2 is not expressed by FGF2-positive Mu¨ller cells (j–
l). In the marmoset, a qualitatively similar pattern of Prdx2
distribution is observed as the rat, although expression by neurons
within the INL appears slightly weaker than in the rat, while
expression by cone photoreceptors is more pronounced (m, n).
Marmoset optic nerve displays no obvious Prdx2 immunolabeling (o).
Scale bar c = 100 lm; a, m = 50 lm; b, d–l, n, o = 25 lm. GCL
ganglion cell layer, INL inner nuclear layer, ON optic nerve, ONH
optic nerve head, ONL outer nuclear layer
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Analysis of retina and optic nerve samples from six rats
revealed a quantifiable level of Prdx3 in each retinal
extract, but not in any of the optic nerve samples
(P\ 0.001 by Student’s unpaired t test; Fig. 5c).
Prdx5
In samples prepared from human and rat brain—positive
control tissues—the Prdx5 antiserum recognized a major
protein band of the expected molecular weight, 17 kDa
(Fig. 6a) plus additional weak higher molecular weight
products. In tissue extracts from marmoset retina and optic
nerve (Fig. 6b), as well as from rat retina and optic nerve
(Fig. 6c), a band at the same molecular weight was also
apparent. Analysis of retina and optic nerve samples from
six rats revealed a quantifiable level of Prdx5 in each
sample. Densitometry revealed there to be a substantially
greater amount of Prdx5 in the retina versus the optic nerve
when normalized for actin (P\ 0.05 by Student’s unpaired
t test; Fig. 6c).
Immunohistochemistry
Prdx3 and Prdx5 displayed patterns of distribution in the rat
and marmoset retina that were strikingly similar to each other
and to those of other mitochondrial markers, such as cyto-
chrome oxidase subunit I and superoxide dismutase 2
(Fig. 7). Indeed, both Prdxs colocalized with cytochrome
oxidase subunit I (data not shown). Prdx3 and Prdx5
immunoreactivities were characterized by strong, punctate
Fig. 5 Western blot analysis of Prdx3 expression in brain, retina and
optic nerve. Molecular weight markers (M, kDa) were used to
determine size of detected gel products. a In tissue extracts from
human and rat brain, a major band of the expected molecular weight
(22 kDa) is apparent. In rat brain, but not retina, an additional major
band is detectable at approximately 75 kD that is not thought to be
related to Prdx3. b In tissue extracts from marmoset retina and optic
nerve, a band of the expected molecular weight is also apparent. Of
note, in certain samples, positive reactivity at the correct molecular
weight was visualized as a doublet rather than a single band. The
additional band may correspond to a modified form of the protein.
c Representative immunoblots from rat retina and optic nerve tissue
extracts, together with quantification of the levels of Prdx3 protein.
All values (represented as mean ± SEM, n = 6) are normalized for
actin, where ***P\ 0.001 by Student’s unpaired t test. Note: nd not
detectable
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labeling in the plexiform layers as well as the somas of the
various cell types, notably RGCs, and also by intense
labeling of photoreceptor inner segments, The superior
morphology afforded by Davidson’s fixative is particularly
well suited to localization of mitochondrial proteins. Inter-
estingly, however, in sections of formalin-fixed rat retina,
Prdx5 showed a greater affinity for labeling parvalbumin-
positive amacrine cells than Prdx3 (data not shown).
Localization of Prdx3 and Prdx5 at the level of the optic
nerve head in the rat and marmoset revealed that both pro-
teins are present in RGC axons, with a relatively higher
abundance in the proximal, mitochondrial-rich, unmyeli-
nated portion of the optic nerve (Fig. 7d, h, k, o). Despite the
apparent lack of Prdx3 in optic nerve extracts as assessed by
Western blotting, both Prdx3 and Prdx5 immunoreactivities
were evident in optic nerve axons (Fig. 7l, p).
Prdx4
Prdx4 is similarly highly conserved among mammals. The
antiserum used in the current study was raised against
recombinant human Prdx4 (without secretion signal pep-
tide) and has previously been demonstrated to recognize
the murine equivalent by Western blotting and immuno-
histochemistry (Goemaere and Knoops 2012).
Western blotting
In the positive control tissues—human and rat brain—the
Prdx4 antiserum recognized a major protein band of the
expected molecular weight (26 kDa). However, the band
was markedly less intense in rat brain and blots featured
additional higher molecular weight bands (Fig. 8a). In
marmoset retina and optic nerve extracts, an intense band
of the expected molecular weight was apparent (Fig. 8b).
In tissue extracts from rat retina and optic nerve (Fig. 8c), a
detectable, but relatively faint, band of the correct molec-
ular weight was evident. Densitometry revealed there to be
a low amount of Prdx4 in the retina and statistically an
even lower amount in the optic nerve when normalized for
actin (P\ 0.01 by Student’s unpaired t test; Fig. 8c).
Immunohistochemistry
In sections of rat brain, retina and optic nerve, no unam-
biguously specific Prdx4 immunoreactivity was observed
Fig. 6 Western blot analysis of
Prdx5 expression in brain, retina
and optic nerve. Molecular
weight markers (M, kDa) were
used to determine size of
detected gel products. a In
tissue extracts from human and
rat brain, a major band of the
expected molecular weight
(17 kDa) is apparent. b In tissue
extracts from marmoset retina
and optic nerve, a major band of
the expected molecular weight
is also apparent.
c Representative immunoblots
from rat retina and optic nerve
tissue extracts, together with
quantification of the levels of
Prdx5 protein. All values
(represented as mean ± SEM,
n = 6) are normalized for actin,
where *P\ 0.05 by Student’s
unpaired t test
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(data not shown). This is not unexpected for two reasons:
firstly, our Prdx4 Western blotting results were uncon-
vincing as regards rat tissue extracts; secondly, Prdx4
immunolabeling in mouse brain was shown to be minor,
diffuse and not well contrasted (Goemaere and Knoops
2012). In human and marmoset tissues, however,
immunohistochemical labeling with the Prdx4 antiserum
produced robust, high contrast, very specific patterns of
staining, which corroborated the Western blotting data. In
human brain, Prdx4 was primarily associated with a pop-
ulation of astrocytes (Fig. 9a). In marmoset retina, strong
labeling was observed in cells with the morphological
characteristic of astrocytes and Mu¨ller cells (Fig. 9b, c),
while in the optic nerve (D, E), Prdx4 staining was likewise
distributed in a pattern characteristic of astrocytes. Con-
firmation of the association of Prdx4 with Mu¨ller cells was
Fig. 7 Representative images of Prdx3 and Prdx5 immunolabeling in
rat (a–h) and marmoset (i–p) retina and optic nerve. Prdx3 (b, c, i,
j) and Prdx5 (f, g, m, n) display very similar patterns of distribution in
the rat and marmoset retina, with both antisera strongly staining the
inner and outer plexiform layers and photoreceptor inner segments
(arrows). Labeling can also be observed in the cytoplasm of various
cell types, notably retinal ganglion cells. The staining patterns closely
match those of other mitochondrial markers, including cytochrome
oxidase (Cyt Ox) subunit I (a) and superoxide dismutase 2 (SOD2, e).
Immunolabeling of sections through the ONH of rat (d, h) and
marmoset (k, l, o, p) shows that both Prdx3 and 5 are present in higher
abundance in the unmyelinated portion of retinal ganglion cell axons
(k, o; yellow arrows) as compared to the zone post-myelination (k, o;
red arrows). Higher magnification images (l, p) show that both Prdx3
and 5 are preferentially associated with axon bundles rather than glial
cells in the optic nerve. Scale bar d, h, k, o = 100 lm; a, b, e, f = 50
lm; c, g, i, j, m, n, l, p = 25 lm. GCL ganglion cell layer, INL inner
nuclear layer, ON optic nerve, ONH optic nerve head, ONL outer
nuclear layer
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achieved by double labeling with glutamine synthetase
(Fig. 9f–h).
Prdx6
As with all of the Prdxs, Prdx6 is highly conserved among
mammals. The antiserum used in the current study was
raised against recombinant rat Prdx6 and has previously
been demonstrated to recognize the human equivalent by
Western blotting and immunohistochemistry (Power et al.
2002).
Western blotting
In samples prepared from human and rat brain—positive
control tissues—the Prdx6 antiserum recognized a major
protein band of the expected molecular weight, 26 kDa
(Fig. 10a). In tissue extracts from marmoset retina and
optic nerve (Fig. 10b), as well as from rat retina and optic
nerve (Fig. 10c), a band at the same molecular weight was
also evident. Analysis of retina and optic nerve samples
from six rats revealed a quantifiable level of Prdx6 in each
sample. Densitometry indicated that there was a higher
level of the Prdx6 protein in the retina versus the optic
nerve when normalized for actin (P\ 0.01 by Student’s
unpaired t test; Fig. 10c).
Immunohistochemistry
In sections of rat brain, Prdx6 was associated with GFAP-
positive astrocytes (data not shown). In the eye, Prdx6 was
expressed by cells with the morphological characteristics
of Mu¨ller cells and astrocytes in the retina (Fig. 11a, b) and
with astrocytes in the optic nerve (Fig. 11c, d). Prdx6 was
observed to colocalize with the Mu¨ller cell markers glu-
tamine synthetase (Fig. 11e–g) and FGF-2 (data not
shown) in the retina and with the astrocytic marker
vimentin in the optic nerve (Fig. 11h–j). There was no
evidence of any association of Prdx6 with retinal neurons,
RGC axons or oligodendrocytes. A similar pattern of Prdx6
distribution was seen in the marmoset retina (Fig. 11k, l)
and optic nerve (Fig. 11m, n), although expression by optic
nerve astrocytes appeared less robust than in the rat and
less pronounced than was observed for Prdx4.
Fig. 8 Western blot analysis of
Prdx4 expression in brain, retina
and optic nerve. Molecular
weight markers (M, kDa) were
used to determine size of
detected gel products. a In
tissue extracts from human and
rat brain, a major band of the
expected molecular weight
(26 kDa) is apparent, which is
markedly more intense in
human compared with rat brain.
b In tissue extracts from
marmoset retina and optic
nerve, a major band of the
expected molecular weight is
also apparent, which is similar
to human brain in intensity.
c Representative immunoblots
from rat retina and optic nerve
tissue extracts, together with
quantification of the levels of
Prdx4 protein. All values
(represented as mean ± SEM,
n = 6) are normalized for actin,
where **P\ 0.01 by Student’s
unpaired t test
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Discussion
The retina is continually exposed to a high level of free
radicals owing to its extremely high metabolic rate com-
bined with the biooxidation effect of light. Accordingly,
endogenous antioxidants, such as Prdxs, play crucial roles
in protecting vulnerable retinal neurons from oxidative
stress (Sacca et al. 2013). In order to begin to elucidate
whether the various Prdx isoforms are potential targets for
therapy during diseases such as age-related macular
degeneration, diabetic retinopathy and glaucomatous optic
neuropathy, we have characterized the basal levels of
expression and cellular distributions of the six isoforms of
the Prdx family in the retina and optic nerve of rodents and
primates. In the retina, Prdx1 and Prdx2 were principally
localized to neurons in the inner nuclear layer as well as
cone photoreceptors, Prdx3 and Prdx5 displayed charac-
teristic mitochondrial patterns of immunolabeling, while
Prdx6 was associated with astrocytes and Mu¨ller cells. In
the optic nerve, Prdx1 was robustly expressed by oligo-
dendrocytes, Prdx3 and Prdx5 were observed in axons, and
Prdx6 was restricted to astrocytes. Prdx2, while present in
Western blotting in optic nerve extracts, was not readily
detectable via immunohistochemistry.
Technical considerations
Preliminary, high throughput screening of the distribution
profiles of the Prdx isoforms in the rat retina has previ-
ously been conducted within the context of a wide-rang-
ing study that examined expression of the thioredoxin,
glutaredoxin and Prdx families throughout the CNS (Aon-
Fig. 9 Representative images of Prdx4 immunolabeling in human
brain, and marmoset retina and optic nerve. In human brain (a),
positive labeling for Prdx4 is associated with a population of
astrocytes. In marmoset retina (b, c), astrocytes and Mu¨ller cells are
robustly labeled by the Prdx4 antiserum, while in the optic nerve (d,
e), Prdx4 staining is distributed in a pattern characteristic of
astrocytes. Double labeling immunofluorescence reveals that Prdx4
colocalizes with the Mu¨ller cell marker glutamine synthetase in the
retina (glut syn; f–h, arrows). Scale bar a, b, d = 50 lm; f–h = 37.5
lm; c, e = 25 lm. INL inner nuclear layer, ONL outer nuclear layer
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Bertolino et al. 2011). Our findings display elements of
commonality with the results of this study, most notably
with regard to the pattern of Prdx3 localization; however,
detailed comparison is challenging owing to the fact that
the authors of the earlier work were unable to discrimi-
nate between glial and neuronal labeling in tissue sections
and did not perform any Western blotting using retinal
extracts. Methodological differences inevitably account
for the vast majority of non-correspondence between
analogous studies, but since categorical demarcation of
specific and non-specific binding is problematic, caution
is advisable when ascribing a pattern of immunolabeling
as definitive. Indeed, significant disparity is evident
between the results of different studies that have exam-
ined the distribution of Prdxs in the brain (Mizusawa
et al. 2000; Jin et al. 2005; Kim et al. 2008; Aon-Ber-
tolino et al. 2011; Dammeyer and Arner 2011; Godoy
et al. 2011; Goemaere and Knoops 2012). With regard to
the present study, the Prdx1-5 antibodies have been
extensively validated in our previously published work in
rodent brain (Goemaere and Knoops 2012), while the
Prdx6 antibody has been carefully verified for use in
human brain tissue (Power et al. 2002, 2008).
Quantitative comparison of the different Prdx isoforms in
rat retina and optic nerve was conducted by qRT-PCR and to
a limited extent by Western blotting. The latter technique is
not reliably quantifiable when used for the purposes of
comparing the endogenous levels of multiple proteins, for
example the Prdxs, in a given tissue, owing to the differing
and unknown affinities of each antiserum for its target pro-
tein. Quantitative inferences can, however, be tentatively
drawn with regard to relative endogenous expression of a
known protein, for example Prdx1, in different tissues, as the
affinity of the antibody should become a constant factor.
Given the quantitative limitations of Western blotting, the
use of qRT-PCR to measure the mRNA levels of each Prdx
isoform was a worthwhile inclusion in the present study. The
advantages of qRT-PCR relate to its specificity, sensitivity
and linearity, which yield data that are quantitatively much
more reliable. Inclusion of mRNA data imparts valuable
perspective on the protein results.
Prdx1 and Prdx2
In the optic nerve, Prdx1 was expressed principally by
oligodendrocytes. The finding is in good agreement with the
Fig. 10 Western blot analysis
of Prdx6 expression in brain,
retina and optic nerve.
Molecular weight markers (M,
kDa) were used to determine
size of detected gel products.
a In tissue extracts from human
and rat brain, a major band of
the expected molecular weight
(26 kDa) is apparent. b In tissue
extracts from marmoset retina
and optic nerve, a major band of
the expected molecular weight
is also apparent.
c Representative immunoblots
from rat retina and optic nerve
tissue extracts, together with
quantification of the levels of
Prdx6 protein. All values
(represented as mean ± SEM,
n = 6) are normalized for actin,
where **P\ 0.01 by Student’s
unpaired t test
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results of various studies in the brain, all of which demon-
strate that Prdx1 localizes to oligodendrocytes (Mizusawa
et al. 2000; Jin et al. 2005; Kim et al. 2008; Goemaere and
Knoops 2012). We also delineated a weak association of
Prdx1 with axons, an observation previously noted in cere-
bral white matter (Mizusawa et al. 2000). With regard to
Prdx2, both the qRT-PCR and Western blotting data showed
there to be a clearly detectable amount of this isoform, yet,
the immunohistochemistry results were inconclusive. There
was no unambiguous localization of Prdx2 to glial cells in the
optic nerve, a finding predicted by the lack of Prdx2
expression in brain glia (Jin et al. 2005; Hattori and Oikawa
2007; Goemaere and Knoops 2012). The logical inference,
therefore, is that Prdx2 is present within RGC axons. This
possibility cannot be discounted from scrutiny of immuno-
labeled tissue sections; nevertheless, it might be anticipated
that there would be an accompanying strong association of
Prdx2 with RGC somas, as was the case for Prdx3 and Prdx5.
This was not evident. In order to resolve the issue, experi-
ments are needed using rats subjected to optic nerve
Fig. 11 Representative images of Prdx6 immunolabeling in rat (a–
j) and marmoset (k–n) retina and optic nerve. In the rat retina (a, b),
positive labeling for Prdx6 is associated with a population of cells in
the INL, with putative Mu¨ller cell end feet, and with astrocytes in the
nerve fibre layer. In the optic nerve, Prdx6 staining is distributed in a
pattern characteristic of astrocytes (c, d). Double labeling immunoflu-
orescence of the retina reveals that Prdx6 colocalizes with the Mu¨ller
cell marker glutamine synthetase (glut syn; e–g, arrows). In the optic
nerve, Prdx6 colocalizes with the astrocytic marker vimentin (h–j). In
the marmoset, a similar pattern of Prdx6 distribution in the retina (k,
l) and optic nerve (m, n) is observed as the rat, although expression by
optic nerve astrocytes is typically weaker than in the rat. Note the
robust labeling of Prdx6 in Mu¨ller cell processes within the Henle
fiber layer (k). Scale bar C = 100 lm; a, h–j, k, m = 50 lm; b, d,
e–g, l, n = 25 lm. GCL ganglion cell layer, INL inner nuclear layer,
ON optic nerve, ret retina
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transection, which causes the loss of RGCs and Wallerian
degeneration of their axons without accompanying death of
glial cells.
In the retina, Prdx1 protein was localized to a population
of cells in the inner nuclear layer and also to cone pho-
toreceptors. A broadly similar pattern of Prdx1 immuno-
labeling has recently been observed in human retinal
sections (Klebe et al. 2014). The Prdx1-positive cells in the
inner nuclear layer were uniformly negative for Mu¨ller cell
markers indicating their status as neurons, which, coupled
with rudimentary inspection of their location, putatively
identifies them as bipolar cells. As the marmoset retina
contains many subclasses of bipolar cells (Chan et al. 2001;
Weltzien et al. 2014), further investigation is needed to
identify which specific types express Prdx1. In the brain,
Prdx1 has been shown either not to be expressed by NeuN-
positive neurons (Jin et al. 2005; Kim et al. 2008), or only
very weakly (Goemaere and Knoops 2012). This was also
true of the NeuN-expressing neurons of the retina, namely
RGCs and amacrine cells. Bipolar cells and photoreceptors,
however, are both highly specialized neurons that do not
express quintessential neuronal markers such as NeuN
(Wolf et al. 1996) and PGP 9.5 (Wilson et al. 1988).
Finally, while we did not detect Prdx1 in Mu¨ller cell
somas, co-localization of signal was evident in some glu-
tamine synthetase-positive Mu¨ller cell endfeet. By way of
reference, Prdx1 is weakly associated with astrocytes in the
brain (Sarafian et al. 1999), and in particular with
perivascular astrocytic feet (Mizusawa et al. 2000; Goe-
maere and Knoops 2012). Prdx2 was localized exclusively
to neurons, specifically to Chx10-positive bipolar cells, to
some calretinin-expressing amacrine cells, and also to cone
photoreceptors. A comparable pattern of Prdx2 immuno-
labeling has recently been reported in human retina (Klebe
et al. 2014). In many respects, the localization pattern of
Prdx2 resembled that of Prdx1, however, some differences
were evident: in the rat, Prdx2 labeling was more robust
than Prdx1 in bipolar cells, less intense than Prdx1 in cone
photoreceptors, and absent from putative Mu¨ller cell end
feet. Conversely, in the marmoset, Prdx2 was less robust
than Prdx1 in inner retinal neurons, but more intense than
Prdx1 in cone photoreceptors, and likewise absent from
putative Mu¨ller cell end feet. The exclusively neuronal
localization of Prdx2 matches the reported cellular distri-
bution of this isoform in brain tissue (Jin et al. 2005;
Hattori and Oikawa 2007; Goemaere and Knoops 2012). In
the brain, as in the retina, there is marked variation in
Prdx2 expression between different neuronal populations.
Implications for disease
Of the retinal neuronal classes, bipolar cells are remarkably
resilient to degeneration in animal models of injury. Our
study shows that bipolar cells, uniquely, express both
Prdx1 and -2 isoforms, a finding that may help explain their
resistance to oxidative injury. With regard to photorecep-
tors, rod photoreceptors displayed negligible expression of
Prdx1 and -2, but cones were associated with both cytosolic
Prdx isoforms. Prdx2 hyperoxidation has been detected in
extracts from a pro-oxidant-treated cultured photoreceptor
cell line (Rezaie et al. 2012), signifying the role of this
protein in buffering oxidative stress. It can be hypothesized
that the absence of Prdx1 and -2 renders rods more vul-
nerable than cones to oxidative stress, and may help
explain why rod loss is greater than cone loss during aging
and in both the early and late stages of age-related macular
degeneration (Curcio et al. 2000). The use of Prdx1 and -2
knockout and over-expressing mice would help test this
hypothesis. Of note, in the brain, transgenic mice overex-
pressing Prdx2 displayed reduced injury and improved
neurological outcome after a focal ischemic insult com-
pared to wild-type littermates (Gan et al. 2012).
Prdx3 and Prdx5
Among the Prdx family, Prdx3 and Prdx5 are distinct in
being localized to mitochondria, where they are believed to
act as redox sensors and peroxide scavengers. Indeed, they
appear to display complementary activities in the matrix
with Prdx3 scavenging hydrogen peroxide and Prdx5 more
effective against peroxynitrite (De Simoni et al. 2008; Cox
et al. 2010). Prdx5, uniquely, can also be associated with
peroxisomes, the cytoplasm and the nucleus (Knoops et al.
2011). In the rodent brain, Prdx3 and Prdx5 are constitu-
tively expressed by neurons (Hattori et al. 2003; Jin et al.
2005; Godoy et al. 2011; Goemaere and Knoops 2012).
The present results show that in the rat and marmoset
retina, Prdx3 and Prdx5 display highly similar patterns of
immunoreactivity that are characteristic of mitochondrial
markers. Of note, the Prdx3 results in the marmoset reflect
those previously reported (Moreira et al. 2008). Prdx3 and
Prdx5 were present in RGC axons, with a relatively higher
content in the mitochondrial-rich, unmyelinated portion of
the nerve. In the rodent brain, Prdx5 displays a wider
distribution profile than Prdx3 (Goemaere and Knoops
2012). Our data likewise show that Prdx5 is expressed to a
greater degree than Prdx3 in the retina and optic nerve.
Implications for disease
In the retina, mitochondrial Prdxs are likely of paramount
importance within RGCs. These neurons are hypothesized
to contain the greatest number of mitochondria of any CNS
neuron, owing to their mitochondrial-rich, unmyelinated
axons (Carelli et al. 2013). Mitochondrial dysfunction
within RGCs is known to be the primary insult in Leber’s
Brain Struct Funct (2016) 221:3903–3925 3921
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hereditary optic neuropathy (Carelli et al. 2004) and is
strongly implicated in the etiology of glaucoma where it
might well be both a trigger for, and consequence of,
oxidative stress (Chrysostomou et al. 2013; Osborne and
del Olmo-Aguado 2013). Given the apparent absence of
cytosolic Prdxs in RGCs, the role of mitochondrial Prdxs is
likely to be critical in preventing cellular build-up of free
radicals. In the brain, expression of Prdx3 increased fol-
lowing transient cerebral ischemia, while intraventricular
administration of Prx3 significantly reduced ischemic
damage, lipid peroxidation and the release of cytochrome c
(Hwang et al. 2010). Prdx3 overexpression also protected
hippocampal neurons from excitotoxic injury (Hattori et al.
2003). Future work should investigate whether manipula-
tion of mitochondrial Prdxs, in particular Prdx3, affects
RGC viability in disease models. The mitochondrial Prdxs
were also, as would be expected, abundantly expressed in
photoreceptors inner segments. It will be informative to
delineate whether Prdx3 becomes hyperoxidised in condi-
tions involving photoreceptor stress.
Prdx4
Of the Prdxs, Prdx4 has arguably proven the most elusive
in terms of definitive establishment of tissue distribution in
the brain. Firstly, global expression of Prdx4 is reported to
be low (Dammeyer and Arner 2011; Godoy et al. 2011;
Kim et al. 2012). Secondly, consensus has not been reached
on which cell types express Prdx4. Neurons, oligodendro-
cytes and astrocytes have all been shown to display posi-
tive immunoreactivity (Jin et al. 2005; Rowe et al. 2010;
Goemaere and Knoops 2012). Our data show robust, high
contrast Prdx4 immunolabeling of macroglial cells of the
primate retina and optic nerve, but no discernible associ-
ation with neurons or oligodendrocytes. These results are
supported by unambiguous Western blots of primate and
human tissue extracts that attest to the specificity of the
antibody. In sections of rat retina and optic nerve, however,
no overtly specific Prdx4 immunoreactivity was observed,
while Western blots indicated only nominal expression of
the protein. There are two possible explanations for the
lack of correspondence between rodents and primates:
either Prdx4 expression is much lower in young adult rats
than aged primates, or, the antibody employed has greater
affinity for human Prdx4 than the rat equivalent. In support
of the former hypothesis, our qPCR data revealed that
Prdx4 mRNA was the least abundant isoform present in rat
retina, and lower than all others excepting Prdx3 (which
was undetectable by Western blotting) in the optic nerve.
Regarding the second hypothesis, Prdx4, like all of the
Prdxs, is a highly conserved protein. FASTA protein
alignment of the human and rat Prdx4 protein reveals vir-
tually identical sequences. It would seem unlikely that rat
Prdx4 fails to recognize an antibody targeted to full length
human Prdx4. We did test additional Prdx4 antibodies
during the course of this study (see Materials and Meth-
ods), but unfortunately they did not provide satisfactory
results by Western blotting on rat, marmoset or human
tissue extracts. Further investigation of Prdx4 expression in
the eye is certainly warranted to confirm or refute the
findings presented herein.
Prdx6
In the retina, Prdx6 was expressed solely by Mu¨ller cells
and astrocytes. The former cell type, despite spanning the
entire thickness of the retina and collectively ensheathing
every neuron, comprises only 4 % of the total number of
cells in the neuroretina (Jeon et al. 1998), which explains
the relative low abundance of Prdx6 mRNA. In the optic
nerve, the immunohistochemical findings were consistent
with the protein being distributed exclusively to astrocytes.
Our results showed a complete correspondence between rat
and marmoset with regard to localization of Prdx6 in the
retina and optic nerve, and similarly match previously
published findings of Prdx6 distribution in human (Power
et al. 2002, 2008) rat (Aon-Bertolino et al. 2011) and
mouse (Godoy et al. 2011; Goemaere and Knoops 2012)
brain, although it should be noted that there is evidence of
Prdx6 expression by brain cell types other than astrocytes
(Jin et al. 2005; Dammeyer and Arner 2011).
Implications for disease
Astrocytes and Mu¨ller cells play crucial structural and
functional roles in maintenance of barrier function; thus,
our finding that these cell types, unique within the retina,
express Prdx6 is of obvious relevance to any disease where
the blood-retinal barrier is compromised, such as diabetic
retinopathy, exudative age-related macular degeneration
and arterial and venous occlusions. In the brain, ischemia–
reperfusion has been shown to cause increased expression
of Prdx6 around hippocampal blood vessels, which was
associated with blood–brain barrier breakdown and reac-
tive astrogliosis (Zhang et al. 2013), while upregulated
Prx6 has also been documented during Alzheimer’s disease
(Power et al. 2008), amyotrophic lateral sclerosis (Strey
et al. 2004) and following traumatic injury (Manevich et al.
2014). It will be of interest to learn whether retinal
pathologies, particularly those of vasogenic origin, corre-
late with increased Prdx6 expression.
Human retina
We have not included a detailed examination of the
expression of the Prdx isoforms in human retina and optic
3922 Brain Struct Funct (2016) 221:3903–3925
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nerve for two reasons: firstly, due to a lack of tissue
extracts suitable for Western blotting; secondly, due to the
fact that the histological preservation of the human eye
sections that were available to us for immunohistochem-
istry was not sufficiently high to engender absolute confi-
dence in any conclusions drawn. With these caveats, it is
nevertheless worth stating that our preliminary data (un-
published observations) indicate that the distribution pro-
file in humans closely matches that of the marmoset. Of
particular note, Prdx4 was clearly evident in Mu¨ller cells
and astrocytes, a cellular distribution that correlates with
our findings in marmoset retina and human brain.
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